From MGIMar 17 2026
Nijmegen, nan Netherlands, 17 March, 2026 - MGI Tech Co., Ltd. (MGI), a institution dedicated to processing devices and technologies that thrust invention successful life sciences, coming announced a awesome milestone successful its collaboration pinch Predica Diagnostics. Predica’s HPV Profiler and CervicaDx assays, based connected its proprietary Cirnaseq technology, person been successfully validated and deployed connected MGI’s DNBSEQ sequencing platforms, delivering a melodramatic simplification successful turnaround clip from 2 weeks to a azygous day.

Image Credit: MGI
The accomplishment marks nan modulation of nan business from first statement little than 2 years agone to real-world impact. Predica has integrated MGI’s DNBSEQ platforms into some its soul R&D and commercialized work projects, pinch aggregate labs receiving results astatine speeds not imaginable connected accepted platforms. The validation confirms that laboratories already moving DNBSEQ systems tin seamlessly incorporated Predica’s Cirnaseq-based diagnostics into their existing workflows.
A Complete, Scalable Solution for Cervical Cancer Screening
MGI’s E25 and G99 sequencers, mixed pinch Predica’s Cirnaseq exertion and Cirnalyzer software, present an affordable and scalable workflow for objective labs, work providers, and nationalist cervical crab screening programs. The integrated solution offers:
- Simultaneous high-resolution HPV genotyping and host-gene look profiling
- Improved specificity for cervical crab consequence appraisal and HPV+ triage
- Automated study and reporting done Predica’s Cirnalyzer software
- Lower costs per sample
Faster R&D, Faster Results
In parallel, Predica’s squad utilized nan level to tally side-by-side comparisons of different room mentation conditions, quickly identifying nan optimal protocol (Figure 1) for nan Cirnaseq platform. The benignant of iterative optimization that utilized to return months tin now beryllium completed successful days.
Figure 1: Optimization of room mentation connected nan MGI E25. Total Assigned Reads (mean ± SD) crossed tested conditions. Image Credit: MGI
Enabling Access Through Technology
“By combining our Cirnaseq assays pinch MGI’s sequencing technology, we’re enabling labs to entree deeper biologic insights astatine a fraction of nan cost,” said Dr. William Leenders, CSO of Predica Diagnostics. “This is portion of our ngo to amended women’s health.“
“By moving Predica’s Cirnaseq assays connected our DNBSEQ platforms, we’re proving that high-accuracy crab diagnostics doesn’t person to travel pinch a precocious value tag aliases slow turnaround. For nan millions of women waiting connected cervical crab screening results, faster turnaround intends little worry and faster treatment. That’s nan effect we’re proud to enable.,” added Dr. Fang Chen, General Manager of Europe & Africa astatine MGI.
Looking ahead, MGI and Predica will jointly validate assays, create autochthonal DNBSEQ room mentation kits, and hole for IVDR submissions. Initial marketplace attraction will beryllium connected Europe and Africa, pinch world description to follow.
About Predica Diagnostics
Predica Diagnostics B.V. is simply a precision-oncology institution processing targeted RNA sequencing tests for early crab detection, consequence stratification, and curen guidance. Founded arsenic a spin-off from Radboudumc, Predica intends to bring its Cirnaseq exertion to objective believe to trim overdiagnosis and overtreatment and amended diligent outcomes.
Learn much about Predica Diagnostics or interaction nan squad at [email protected]
English (US) ·
Indonesian (ID) ·